Disease
Heart Failure
Reduced ability of the heart to pump or fill with blood, spanning the HFrEF/HFmrEF/HFpEF ejection-fraction spectrum and acute/chronic presentations.
Total attributable cost
$27.7B
$3,594/patient
Drug spend
$9.1B
$1,188/patient
33% of total cost is drugs
All severities (2021-2023 NHANES cycle) · US